photo: © International Ice Hockey Federation
The IIHF imposed a 3-month suspension on Phillip Marinaccio due to a violation of Articles 2.1 and 2.2 of the IIHF Anti-Doping Code.
During an IIHF Team Whereabouts out-of-competition test on 3 April 2023, the player tested positive for terbutaline, a prohibited substance listed on the WADA Prohibited List under S3. Beta-2 Agonists as a specified substance.
The IIHF considered that the Anti-Doping Rule Violation was not committed intentionally, and that the player’s fault was not significant. Specifically, the player established that the source of the prohibited substance was an inhaler prescribed to him by a doctor and declared by the player on the doping control form.
The player was provisionally suspended as of 20 June 2023, and his 3-month suspension started on that date.
During an IIHF Team Whereabouts out-of-competition test on 3 April 2023, the player tested positive for terbutaline, a prohibited substance listed on the WADA Prohibited List under S3. Beta-2 Agonists as a specified substance.
The IIHF considered that the Anti-Doping Rule Violation was not committed intentionally, and that the player’s fault was not significant. Specifically, the player established that the source of the prohibited substance was an inhaler prescribed to him by a doctor and declared by the player on the doping control form.
The player was provisionally suspended as of 20 June 2023, and his 3-month suspension started on that date.